Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Geisbert

Showing results (181-190 of 279) with videos related to

Pageof 28
Sort By:
The Journal of Infectious Diseases|December 21, 2012
Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic feverLauren M Smith, Lisa E Hensley, Thomas W Geisbert, et al.
Plos Neglected Tropical Diseases|May 27, 2022
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challengeCourtney Woolsey, Robert W Cross, Krystle N Agans, et al.
Cell|August 10, 2019
Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus NeutralizationKathryn M Hastie, Robert W Cross, Stephanie S Harkins, et al.
The Journal of Clinical Investigation|November 29, 2022
Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus diseaseCourtney Woolsey, Viktoriya Borisevich, Alyssa C Fears, et al.
Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.
The Journal of Infectious Diseases|May 12, 2023
A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola VirusCourtney Woolsey, Viktoriya Borisevich, Krystle N Agans, et al.
Nature|April 23, 2015
Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primatesEmily P Thi, Chad E Mire, Amy C H Lee, et al.
The Journal of Infectious Diseases|June 26, 2015
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola VirusDemetrius Matassov, Andrea Marzi, Terri Latham, et al.
The Journal of Clinical Investigation|November 7, 2017
siRNA rescues nonhuman primates from advanced Marburg and Ravn virus diseaseEmily P Thi, Chad E Mire, Amy Ch Lee, et al.
Emerging Infectious Diseases|October 20, 2020
Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa FeverLucy E Horton, Robert W Cross, Jessica N Hartnett, et al.
Pageof 28

Showing results (181-190 of 279) with videos related to

Sort By:
Pageof 28
The Journal of Infectious Diseases|December 21, 2012
Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic feverLauren M Smith, Lisa E Hensley, Thomas W Geisbert, et al.
Plos Neglected Tropical Diseases|May 27, 2022
A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challengeCourtney Woolsey, Robert W Cross, Krystle N Agans, et al.
Cell|August 10, 2019
Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus NeutralizationKathryn M Hastie, Robert W Cross, Stephanie S Harkins, et al.
The Journal of Clinical Investigation|November 29, 2022
Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus diseaseCourtney Woolsey, Viktoriya Borisevich, Alyssa C Fears, et al.
Science Translational Medicine|June 27, 2014
Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibodyThomas W Geisbert, Chad E Mire, Joan B Geisbert, et al.
The Journal of Infectious Diseases|May 12, 2023
A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola VirusCourtney Woolsey, Viktoriya Borisevich, Krystle N Agans, et al.
Nature|April 23, 2015
Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primatesEmily P Thi, Chad E Mire, Amy C H Lee, et al.
The Journal of Infectious Diseases|June 26, 2015
Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola VirusDemetrius Matassov, Andrea Marzi, Terri Latham, et al.
The Journal of Clinical Investigation|November 7, 2017
siRNA rescues nonhuman primates from advanced Marburg and Ravn virus diseaseEmily P Thi, Chad E Mire, Amy Ch Lee, et al.
Emerging Infectious Diseases|October 20, 2020
Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa FeverLucy E Horton, Robert W Cross, Jessica N Hartnett, et al.
Pageof 28